Huons Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HUONS
HUONS has two approved drugs.
Drugs and US Patents for Huons
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Huons | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 212821-002 | Jun 15, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Huons | BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;SPINAL | 212822-001 | Dec 30, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Huons | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 212821-001 | May 7, 2020 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

